The objective is to understand the mechanism of androgen receptor regulation of gene expression. The immediate goals are to [1] purify androgen receptor and 8S androgen receptor-promoting factor (8S-PF) for preparation of monoclonal antibodies, [2] elucidate the mechanism of androgen receptor transformation to the active nuclear binding form, and [3] identify those components of the nuclear matrix required for receptor binding. Crucial toward progress in understanding the mechanism involved in androgen receptor activation of genes will be receptor purification and preparation of monoclonal antibodies. Methods for androgen receptor purification include affinity chromatography on steroid matrixes and an 8S-PF Sepharose affinity column. Through the use of 8S receptor stabilizing agents such as sodium molybdate and zinc, the nonactivated 8S receptor will be purified. Covalent coupling of a labeled androgen ([3H]7Alpha,17Alpha-dimethyl-19-nor-testosterone) to receptor will enable purification of receptor by electrophoresis on denaturing gels. Monoclonal antibodies to receptor and 8S-PF will be prepared which should permit precise immunocytochemical studies on cellular localization and provide a method for analysis of the steroid-free receptor. With regard to androgen receptor transformation and nuclear binding, a working model is proposed that incorporates the recent observations of this laboratory that zinc potentiates receptor binding to nuclear matrix whereas 8S-PF inhibits receptor binding. The effects of Zn2+, and other divalent cations, in particular Ca2+ and Mg2+, on the formation and dissociation of the receptor-8S-PF complex and on nuclear matrix binding will be investigated. The possible role of calmodulin in Ca2+-induced receptor transformation will be established. In addition, it will be determined if receptor phosphorylation effects receptor transformation and/or matrix binding. If a small RNA is found to be a component of the 8-9S receptor, its role in receptor transformation will be investigated. Receptor transformation will be monitored by sucrose gradient centrifugation and by binding to nuclear matrix and DNA-Sepharose. Finally, efforts will be made to identify, isolate and establish the androgen dependence of the acceptor component of nuclear matrix responsible for receptor binding.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
2R01HD016910-05
Application #
3314031
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1982-08-01
Project End
1988-08-31
Budget Start
1986-09-01
Budget End
1987-08-31
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Tan, Jiann-An; Bai, Suxia; Grossman, Gail et al. (2014) Mechanism of androgen receptor corepression by CK?BP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer. Mol Cell Endocrinol 382:302-313
Su, Shifeng; Minges, John T; Grossman, Gail et al. (2013) Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins. J Biol Chem 288:24809-24
Minges, John T; Su, Shifeng; Grossman, Gail et al. (2013) Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers. J Biol Chem 288:1939-52
Askew, Emily B; Minges, John T; Hnat, Andrew T et al. (2012) Structural features discriminate androgen receptor N/C terminal and coactivator interactions. Mol Cell Endocrinol 348:403-10
Cherian, Milu T; Wilson, Elizabeth M; Shapiro, David J (2012) A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes. J Biol Chem 287:23368-80
Titus, Mark A; Zeithaml, Brian; Kantor, Boris et al. (2012) Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer. PLoS One 7:e30192
Su, Shifeng; Blackwelder, Amanda J; Grossman, Gail et al. (2012) Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation. J Biol Chem 287:34809-24
Lagarde, William H; Blackwelder, Amanda J; Minges, John T et al. (2012) Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation. J Biol Chem 287:10905-15
Liu, Qiang; Su, Shifeng; Blackwelder, Amanda J et al. (2011) Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor. J Biol Chem 286:29951-63
Mohler, James L; Titus, Mark A; Bai, Suxia et al. (2011) Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer. Cancer Res 71:1486-96

Showing the most recent 10 out of 18 publications